These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8281235

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Ovarian activity and bleeding patterns during extended continuous use of a combined contraceptive vaginal ring.
    Davies GC, Feng LX, Newton JR, Dieben TO, Coelingh-Bennink HJ.
    Contraception; 1992 Sep; 46(3):269-78. PubMed ID: 1451522
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Effects of the oral administration of a contraceptive on lipid balance and on the concentration of serum tocopherol].
    Martino F, Lapiana C, Di Salvo G, Galati G, Avitto P, Lubrano R.
    Minerva Ginecol; 1988 Sep; 40(9):557-8. PubMed ID: 2975772
    [No Abstract] [Full Text] [Related]

  • 9. [Hormonal contraception with gestagens].
    Petersen KR, Poulsen EF.
    Ugeskr Laeger; 2001 Aug 20; 163(34):4553-6. PubMed ID: 11530558
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
    Ahrendt HJ, Nisand I, Bastianelli C, Gómez MA, Gemzell-Danielsson K, Urdl W, Karskov B, Oeyen L, Bitzer J, Page G, Milsom I.
    Contraception; 2006 Dec 20; 74(6):451-7. PubMed ID: 17157101
    [Abstract] [Full Text] [Related]

  • 12. Pharmacodynamic studies with a new progestational substance -- ORG 2969 -- in combination with ethinyloestradiol.
    Alapiessa U, Assendorp R, Hirvonen E, Hulkko S, Järvi K, Korhonen M, Käär K, Lauslahti K, Liukko P, Lumiala I, Pora O, Punnonen R, Rhen K, Ruokonen A, Saranen M, Tarkkila T, Viinikka L, Virkkunen P, Weijers M, Widholm O.
    Acta Obstet Gynecol Scand Suppl; 1979 Dec 20; 85():1-21. PubMed ID: 377898
    [No Abstract] [Full Text] [Related]

  • 13. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE, Holder A, Evans-Strickfaden T, Nyagol B, Makanga M, Oyaro B, Humwa F, Williams T, McLellan-Lemal E, Desai M, Huey MJ.
    Contraception; 2017 Jun 20; 95(6):602-604. PubMed ID: 28372978
    [Abstract] [Full Text] [Related]

  • 14. The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.
    Verhoeven CH, Dieben TO.
    Contraception; 2004 Mar 20; 69(3):197-9. PubMed ID: 14969666
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Route of administration of contraceptives containing desogestrel/etonorgestrel and insulin sensitivity: a prospective randomized study.
    Cagnacci A, Ferrari S, Tirelli A, Zanin R, Volpe A.
    Contraception; 2009 Jul 20; 80(1):34-9. PubMed ID: 19501213
    [Abstract] [Full Text] [Related]

  • 19. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jul 20; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.